This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated SET Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SET WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~33.5 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Alternative isoform sizes | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 4 isoform(s) |
The M02211 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HepG2 cell lysate (catalog M02211) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02211; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SET has a predicted 33.5 kDa monomer; splice isoforms may add bands, and its homodimer may appear higher if it remains associated.
| Band near 33.5 kDa | SET monomer near its predicted mass |
| Several bands at different positions | SET isoforms 1, 2, 3, and 4 may differ in size |
| Band near twice the monomer size under nonreducing conditions | SET homodimer may remain associated |
| Fragments below the main band | SET may have undergone GZMA cleavage |
| Predicted SET mass | Places the full-length monomer near 33.5 kDa |
| Isoforms 1 and 2 | Alternative splicing may produce bands at different positions |
| Isoforms 3 and 4 | Alternative splicing may produce additional bands at different positions |
| SET homodimer | May produce a band near twice the monomer size if it remains associated |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | SET may be below detection in the sampled lysate | Check sample loading and enrich the cytosolic or nuclear fraction |
| Band higher than expected | SET homodimer may remain associated | Compare denaturing and nonreducing preparations |
| Band lower than expected | A different SET splice isoform may be detected | Check which isoforms the antibody recognizes |
| Multiple bands | SET has four named isoforms | Compare bands with isoform-specific expression or depletion |
| Weak or no signal | SET abundance may differ between sampled compartments | Compare cytosolic and nuclear fractions |
| Fragments below expected size | GZMA cleavage of SET may generate fragments | Check whether the sample underwent GZMA exposure |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Heart muscle | cardiomyocytes | Low | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Cerebral cortex | endothelial cells | Medium | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Medium | Protein (IHC) | HPA → |
| Lung | alveolar cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SET, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
M02211 is the listed anti-SET antibody with a Western blot image from HepG2 cell lysate. The supplied record does not establish best-performing status, citation history, thorough validation, or orthogonal cross-validation against negative tissue or complementary methods.
Which to pick: Only M02211 is listed. Choose it if a HepG2 lysate Western blot example fits your experiment; confirm reactivity and validation for your sample before use.